Company news

Covalon Technologies Ltd. (TSXV:COV) news

Covalon Technologies Ltd. news releases on 6ix. Latest, Sep 28, 2026: Contamination Protection Solution Highlights Covalon’s Presence at the Association…

Covalon Technologies Ltd. (TSXV:COV) news

Press releases & updates

Contamination Protection Solution Highlights Covalon’s Presence at the Association for Vascular Access 2026 Annual Scientific Meeting

Covalon Reports Encouraging Findings From Real World Evidence Analysis Comparing Collagen Dressings

Covalon to Present at the 2026 Annual Smallcap Discoveries Conference After Reporting Revenue Growth of 20% and Gross Margin of 67%

Covalon Reports Fiscal 2026 Third Quarter Results

Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2026 Results

Covalon Announces Appointment of New Director and DSU Grants

Covalon Reports 2026 Second Quarter Results

Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2026 Results

Covalon Technologies Reports Significant Milestones Spanning Vascular Access, Infection Prevention, and Wound Care

Covalon to Showcase Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting

Covalon Announces Grant of Deferred Share Units

Covalon Announces Voting Results from Fiscal 2025 Annual General and Special Meeting of Shareholders

Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 25, 2026

Covalon Reports on 2026 First Quarter Results and Recent Achievements and Highlights

Covalon Honoured to Partner with the Association for Vascular Access and Global Expert Dr. Nancy Moureau to Tackle Critical IV Therapy Complications

Covalon Announces Conference Call to Discuss First Quarter Fiscal 2026 Results

Covalon Reports Highest Revenue Quarter of Fiscal Year 2025, Delivers Third Consecutive Year of Revenue Growth

Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2025 Financial Results

Covalon Technologies Ltd. Announces Payment of First Ever Dividend, Marking a Milestone in Financial Strength

Covalon Declares First Ever Special Cash Dividend

Covalon to Participate in the Planet MicroCap Showcase: TORONTO on October 22, 2025

Empowering Nurses with Innovation: Covalon Showcases Patient Safety Solutions to Tackle Preventable Complications at ANCC National Magnet & Pathway Conference

Covalon Presents Evidence-Backed Innovations Making a Difference for Critically Ill Children at APHON

Covalon Announces Departure of Executive Chair and the Appointment of its Largest Shareholder as New Chair

Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon’s Presence at the Association for Vascular Access 2025 Annual Meeting

Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon's Presence at the Association for Vascular Access 2025 Annual Meeting

Covalon Announces Publication of Impactful VALGuard&#xAE; Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs)

Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs)

Covalon Reports Strong Sequential Quarter on Quarter and Trailing Twelve Months Performance

Covalon Technologies Ltd. Achieves DTC Eligibility in the United States

CORRECTING and REPLACING Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2025 Financial Results

Covalon Reports Fifth Consecutive Quarter of Positive Earnings

Covalon Announces Exciting New Clinical Research Evaluating VALGuard&#xAE; Vascular Access Line Guard

Covalon Announces Exciting New Clinical Research Evaluating VALGuard® Vascular Access Line Guard

Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2025 Financial Results

Covalon Retains Financial and Strategic Advisor to Advise on Shareholder Value-Enhancing Opportunities

Covalon Announces Promotion of Kim Crooks to Chief Operating Officer and Appointment to Board of Directors

Covalon to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, May 6, 2025

Covalon to Present at the Planet MicroCap Showcase: VEGAS on April 23, 2025

Covalon Technologies Ltd. Poised for Strong Benefit From Positive US Tariff Outcome

Covalon Announces Voting Results from Fiscal 2024 Annual Meeting of Shareholders

Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 19, 2025

Covalon Reports Fourth Consecutive Quarter of Year over Year Revenue Growth and Positive Earnings

Covalon Technologies Ltd. Named as a TSX Venture Exchange 2025 Top 50 Company

Covalon Announces Conference Call to Discuss First Quarter Fiscal 2025 Financial Results

Keynotes and 50 Companies to Present at the Planet MicroCap Showcase: VANCOUVER in association with Small Cap Discoveries on September 25-26, 2024 at the Fairmont Waterfront Vancouver

Covalon to Present at the Planet MicroCap Showcase: VANCOUVER 2024 in association with Small Cap Discoveries on Thursday, September 26, 2024 at 10:00 a.m. PST

Compassionate Care Solutions Provider Covalon Participating in the Canadian Vascular Access Association and World Congress on Vascular Access Joint Conference on April 26-28, 2023 in Toronto

Covalon to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 & Hold 1x1 Meetings on Thursday, April 27, 2023

Covalon Presents New CLABSI Conscious Series Webinar: Protecting CVADs from Gross Contamination

Covalon Announces Publication of Impactful VALGuard® Line Guard Clinical Study Demonstrating Significant Reduction in Central Line-Associated Blood Stream Infections (CLABSIs)

Covalon Announces Exciting New Clinical Research Evaluating VALGuard® Vascular Access Line Guard